Academia.eduAcademia.edu

Outline

Malignant growth Maxilla management an analysis

2013, Otolaryngology Online Journal

Abstract

Malignant tumors involving maxilla is rather rare. This comprises about 1% of all malignant tumors seen in humans. This tumor constitutes roughly 3% of all head and neck malignancies. This article discusses our experience in managing patients with malignant tumors of maxilla. All our patients underwent total maxillectomy followed by post operative irradiation. Mean survival rates of our patients ranged from 2.5 years to 3 years. Survival rates were also dependent on the histology of the tumor. This is a retrospective study of patients who presented to our Institution between 2006-2010. In our study we found that surgery had a definitive role despite the staging. Even advanced cases had a definite improvement in the quality of life. All our patients received post operative irradiation (full course) following total maxillectomy.

References (8)

  1. Grant RN, Silverberg E. Cancer Statistics 1970. American Cancer Society, New York, 1970
  2. Carrau RL, Myers EN, Johnson JT. Paranasal sinus carcinoma -diagnosis, treatment, and prognosis. Oncology 1992;6:43-50.
  3. Kraus DH, Roberts JK, Medendorp SV, et al. Non squamous cell malignancies of the paranasal sinuses. Ann Otorhinolaryngol 1990;99:5-11.
  4. Spiro JD, Soo KC, Spiro RH. Non squamous cell malignant neoplasms of the nasal cavities and paranasal sinuses. Head Neck l995;17:114-118.
  5. Tiwari R, Hardillo JA, Mehta D, et al. Squamous cell carcinoma of maxillary sinus. Head Neck 2000;22:164-169.
  6. Bhattacharyya N. Factor affecting survival in maxillary sinus cancer. J Oral Maxillofac Surg 2003;61:1016-1021.
  7. Lewis JS, Castro EB. Cancer of the nasal cavity and paranasal sinuses. Journal of Laryngology Otology 1972; 86: 255.
  8. Paulino AC, Marks JE, Bricker P, Melian E, Reddy SP, Emami B. Results of treatment of patients with maxillary sinus carcinoma. Cancer 1998;83:457-465